PUMA regulates germ cell loss and primordial follicle endowment in mice
Michelle Myers(Nucana (United Kingdom)), Karla J. Hutt(Discovery Institute), Thilini Gamage(Hudson Institute of Medical Research), Seng H. Liew(Prince of Wales Hospital), Antony Sutherland(Hudson Institute of Medical Research), Michele Cook(Walter and Eliza Hall Institute of Medical Research), Andreas Strasser(The University of Melbourne), Mai A. Sarraj, F. Hamish Morgan(Hudson Institute of Medical Research), Clare L. Scott(Walter and Eliza Hall Institute of Medical Research), Jock K. Findlay, Nadeen Zerafa(Hudson Institute of Medical Research), J. B. Kerr(Barrie Urology Group), Ileana Kapic(Hudson Institute of Medical Research)
Cited by 70
Related Papers
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
|The Lancet|2010|2.3k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis.
|The EMBO Journal|1995|788
Methods for quantifying follicular numbers within the mouse ovary
|Reproduction|2004|764